Edwards to eliminate 70 jobs in reorganization
From Reuters
Edwards Lifesciences Corp. said that it had dropped its laser treatment for a type of abnormal heart rhythm and that it would cut 70 jobs and take a $16-million pretax charge as it reorganized operations.
Irvine-based Edwards, best known as a maker of heart valves, said it discontinued its Optiwave 980 Cardiac Laser Ablation system designed to treat atrial fibrillation, a common but difficult-to-treat heart rhythm in which the upper chambers of the heart beat out of sync.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
